Amble Review

Amble's pitch: one flat price that never climbs as your dose does

Amble is a straightforward, mainstream telehealth route to compounded GLP-1 medication, and its single most useful idea is right there in its own marketing: "same price, every dose." Most compounding programs quietly raise your bill as you titrate up to a higher milligram strength. Amble doesn't. You pay $179 a month for compounded semaglutide whether you're on a starter dose or a full maintenance dose, and that predictability is the real reason to consider it. If you've been burned by a program where month four cost noticeably more than month one, this is the antidote.

Is it worth it? For someone who wants no-drama, all-50-states access to a GLP-1 without doing a lot of homework, yes. Amble is deliberately simple. The flip side is that it's also light on public detail, so go in knowing you're buying convenience and a clean price, not a deeply documented clinical program.

How the pricing actually works

Amble uses flat, all-inclusive pricing rather than the dose-tiered ladders you'll see elsewhere. Compounded semaglutide starts at $179 per month. Compounded tirzepatide — the dual-action molecule behind Mounjaro and Zepbound — sits higher, beginning in the high-two-hundreds and ranging up toward the low-three-hundreds a month depending on your program. For context, the category median across the providers we track lands around $170, so semaglutide through Amble runs a touch above the middle of the pack while still well under the four-figure cash prices the brand-name pens command at retail.

The number that matters is what's bundled into it. Amble states that medication, supplies, and shipping are all included, plus the clinician consult — there's no separate membership tacked on top of the drug. That's important when you compare quotes: a lower sticker price elsewhere can hide a separate consult fee, a shipping charge, or a syringe-and-supplies upcharge that Amble folds into the one figure.

• Flat by design: the same monthly price holds as you titrate to higher doses
• Bundled: medication, supplies, and shipping included in the quoted price
• No teaser rate: Amble doesn't publish a discounted first-month promo, so the price you see is the price you keep
• Fine print to know: pricing is described as subject to change and excludes promotions

The medications and how you get them

Amble offers both of the heavyweight GLP-1 options: semaglutide and tirzepatide. Having both under one roof matters because they're not interchangeable — tirzepatide hits a second hormone receptor and tends to drive larger losses in trials, while semaglutide is the more established, lower-cost starting point. Being able to start on one and switch within the same program, without re-onboarding somewhere new, is a genuine convenience.

The process is fully online: Amble connects you to a licensed clinician, the prescription is filled as a compounded GLP-1, and it ships to your door with the supplies you need to inject. There's no clinic visit and no pharmacy pickup.

What you're actually buying — and what to verify

This is the honest caveat. Amble's medications are compounded, not the FDA-approved brand-name pens. Compounded GLP-1s are mixed by a pharmacy rather than manufactured by Lilly or Novo Nordisk, which is how the price stays low — but it also means the specific pharmacy, its accreditation, and its sourcing aren't something Amble publishes prominently. Our record carries no named, accreditation-verified compounding partner for Amble and no FDA warning letters on file, which is a clean-but-thin picture: nothing negative, but less third-party documentation than the most transparent programs offer.

So before you commit, ask Amble directly which compounding pharmacy fills your prescription and whether it's a state-licensed 503A or a 503B outsourcing facility. A program with nothing to hide will answer plainly.

Who should choose Amble — and who should skip it

Amble is a strong fit if you want both major GLP-1 options, value a price that won't creep upward as you increase your dose, and live anywhere in the U.S. — it advertises availability in all 50 states (with some exclusions). It's also a good pick for people who find most telehealth checkouts confusing and just want one number that covers everything.

Skip it if you specifically need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound — Amble's lane is compounded, and there's no brand-name pricing on file. Skip it, too, if pharmacy-level transparency is a dealbreaker for you. Detail-oriented patients who want to see the exact compounding partner, accreditation, and clinical-oversight model spelled out up front will find Amble's public information thinner than they'd like.

Bottom line

Amble does one thing unusually well: it removes the pricing anxiety from a GLP-1 program. A flat, all-inclusive $179 a month for compounded semaglutide that doesn't rise with your dose, both molecules available, and nationwide reach make it a sensible mainstream option. Just treat the lighter public detail as a prompt, not a stop sign — confirm the compounding pharmacy and how clinician oversight works before your first shipment. Compare it against the field using our scoring methodology, and if simple, predictable pricing is what you're after, Amble earns its spot on the shortlist.

For a side-by-side, Sunlight ($159/month) and Bodybuilding Health+ ($179/month) are the most comparable options to weigh against Amble.